AMCP formed the PAC to support candidates who promote policies that improve the practice of managed care pharmacy. Prescription drug prices consistently rank as a top issue for voters, so it’s important to ensure that the managed care perspective is represented in these policy conversations.

Join us in celebrating 30 years of JMCP and advancing the dialogue in managed care pharmacy through research, innovation, and real-world application, fostering collaboration and driving impactful change.

A coalition of 34 scientific and medical organizations led by the American Association of Immunologists and the American College of Physicians released the following statement.

A new Academy of Managed Care Pharmacy Foundation report, “Emerging Trends Impacting Managed Care Pharmacy,” developed in partnership with Pfizer, warned of significant shifts within managed care pharmacies fueled by AI adoption, drug shortages and affordability challenges.

The Protecting Pharmacies in Medicaid Act would prohibit the use of spread pricing arrangements in Medicaid programs. Pharmacy benefit managers (PBMs) would be required to pass through to pharmacies the full amount of the money paid to the PBMs by Medicaid programs, except for a fixed administrative fee. The total reimbursement amount will be determined by a survey of national average drug acquisition costs administered by the Department of Health & Human Services.

In AMCP's latest comments to the FDA, we emphasize the need for standardized public reporting of confirmatory trial progress, ensuring payers and health care providers have the necessary data to make informed coverage decisions. By supporting proactive communication and rigorous confirmatory trials, AMCP aims to balance early access to innovative treatments with patient safety and long-term therapeutic value.